Floatz logo

Ephedrine, Anhydrous

Carotid Stenosis

University Hospital, Clermont-FerrandSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Carotid Stenosis cohort.

View all 25

Same molecule, other indications

Ephedrine, Anhydrous is also rated in:

hypotensive disorderDormant
BB
Indicative · Phase 4
69 / 100
View asset →
cardiovascular disorderActive
BB
Indicative · Phase 4
68 / 100
View asset →
obesity disorderDormant
B
Indicative · Phase 3
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →